Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Apr 2019 EMA Starts New Review of Risks with High-strength Estradiol-containing Creams Gynaecologic malignancies - Epidemiology/Etiology/Cancer Prevention
15 Apr 2019 FDA Grants Accelerated Approval to Erdafitinib for Metastatic Urothelial Carcinoma Genitourinary cancers - Personalised medicine - Anticancer agents & Biologic therapy
12 Apr 2019 FDA Expands Pembrolizumab Indication for First-line Treatment of NSCLC (TPS ≥1%) Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
11 Apr 2019 First-line Durvalumab Improves Survival Compared to Chemotherapy in Metastatic NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
11 Apr 2019 Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer [ELCC Press Release] Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
10 Apr 2019 PROs Were Consistent with the ITT Population Across PD-L1 Subgroups in Patients with Stage III NSCLC Receiving Durvalumab or Placebo Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
10 Apr 2019 Studies give new insights on immunotherapy in elderly patients with advanced NSCLC [ELCC Press Release] Lung and other thoracic tumours - Cancer in Special Situations / Population - Cancer Immunology and Immunotherapy
09 Apr 2019 LOXO-195 Shows Promise in Tumours with Acquired Resistance to First-generation TRK-targeted Agents Personalised medicine - Anticancer agents & Biologic therapy
08 Apr 2019 FDA Expands Approved Use of Palbociclib for Metastatic Breast Cancer Breast cancer - Cancer in Special Situations / Population - Anticancer agents & Biologic therapy
03 Apr 2019 Global Microbial Signatures Specific for Colorectal Cancer Revealed Gastrointestinal cancers
02 Apr 2019 EMA Recommends Extension of Indications for Plerixafor Cancer in Special Situations / Population
01 Apr 2019 EMA Recommends Extensions of Indication for Lenalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
29 Mar 2019 EMA Recommends Extension of Indications for Pomalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
28 Mar 2019 EU Actions to Prevent Medicine Shortages Due to Brexit Bioethics, legal and economic issues
27 Mar 2019 Glucocorticoids Promote Breast Cancer Metastases Breast cancer - Translational research